Intricon (IIN) Peer Comparison

$24.24

$0.01 (0.04%)

As on 24-May-2022 16:00EDT

Market cap

$225 Mln

Revenue (TTM)

$127 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Edit

	Intricon (IIN)	Antares Pharma (ATRS)
Market cap ($ Mln)	225	955
Revenue ($ Mln)	127	183
Net Profit ($ Mln)	-1.48	42.46
Net Margin (%)	-1.17	23.16
RoE (%)	-2.56	26.82
Price to Earnings	--	24.09
Price-To-Book	2.41	5.43

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Intricon (IIN)	Antares Pharma (ATRS)
Operating Revenue	126.50	183.46
Cost of Revenue	94.45	70.60
Gross Profit	31.39	115.70
Operating Expenses	31.81	112.69
Operating Profit (EBIT)	-0.79	57.72
Other Income	-0.47	-0.15
Profit before Tax	-1.27	54.75
Provision for Tax	0.06	12.29
Profit after Tax (Net Income)	-1.48	42.46
Minority Interest	0.15	0.00
Consolidated Profit	-1.48	40.18

Liabilities ($ Mln)

	Intricon (IIN)	Antares Pharma (ATRS)
Shareholder's Funds	93.61	175.77
Minority Interest	0.15	0.00
Non-Current Liabilities	8.80	24.16
Current Liabilities	23.95	55.73
Total Liabilities	122.46	257.51

Assets ($ Mln)

	Intricon (IIN)	Antares Pharma (ATRS)
Non-Current Assets	49.90	84.07
Current Assets	76.62	171.59
Total Assets	122.36	257.51
Total Debt*	6.36	25.49
Net Current Assets	52.67	115.86

Cashflow ($ Mln)

	Intricon (IIN)	Antares Pharma (ATRS)
Cash From Operating Activities	0.44	36.62
Cash Flow from Investing Activities	-2.22	-3.85
Cash from Financing Activities	-1.15	-19.99
Net Cash Inflow / Outflow	-2.94	12.78

Ratios

Profitability Ratios

	Intricon (IIN)	Antares Pharma (ATRS)
ROCE (%)	-0.11	25.65
ROE (%)	-2.56	26.82
ROA (%)	-0.99	14.11
EBIT Margin (%)	-1.12	30.97
Net Margin (%)	-1.17	23.16
Cash Profit Margin (%)	0.00	0.00

Growth Ratios

	Intricon (IIN)	Antares Pharma (ATRS)
Revenue Growth (%)	11.91	15.67
EBIT Growth (%)	-569.54	179.19
Net Profit Growth (%)	-973.96	-31.90
EPS Growth (%)	-1,647.77	-33.85
Book Value Growth (%)	12.69	43.35

Valuation Ratios

	Intricon (IIN)	Antares Pharma (ATRS)
Price / Earnings	-1,372.92	13.50
Price / Book Value	1.55	3.55
Dividend Yield (%)	--	--
EV/EBITDA	22.49	8.79
Market Cap ($ Cr)	--	--

Solvency Ratios

	Intricon (IIN)	Antares Pharma (ATRS)
Debt to Equity	0.00	0.10
Short term debt to equity ratio	0.02	0.01
Current Ratio	3.20	3.08
Quick Ratio	2.01	2.87
Interest Coverage	-27.29	20.39

Operating Efficiency Ratios

	Intricon (IIN)	Antares Pharma (ATRS)
Debtors to sales (%)	18.72	50.85
Asset Turnover	0.85	0.61
Receivable days	56.79	132.39
Inventory Days	85.59	79.60
Payable days	35.17	88.93
Cash Conversion Cycle	107.21	123.05

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly